La investigación clínica en vacunasEl futuro
- José María Eiros 1
- A Pérez Rubio 2
- María Rosario Bachiller 1
-
1
Universidad de Valladolid
info
-
2
Hospital Universitario de Valladolid
info
ISSN: 1697-090X
Año de publicación: 2018
Número: 1
Páginas: 17-23
Tipo: Artículo
Otras publicaciones en: Revista Electrónica de Biomedicina
Resumen
The field of infectious diseases includes vaccines against bacteria, viruses, fungi and parasites, which employ various strategies and production techniques. They are aimed at the identification of new protective antigens (reverse vaccinology, structural vaccinology and immunommunology), the acquisition or enhancement of immunogenicity (vaccination, system vaccinology) and the use of new adjuvants and delivery modalities, heterologous vaccination, conjugation from polysaccharides to proteins and the adversomic. Among the innovative administration routes: the digestive, mucous, and transcutaneous. And as new types of vaccines: recombinants (with or without vectors), nucleic acids, peptide, attenuated and molecularly inactivated, rearranged viruses (rearranged) and adapted to cold. The criteria that should prevail in order to implement "useful" vaccination strategies in our environment must assess the economic and social impact of prevention programs.